Comparison between DISHMAN PHARMACEUTICALS CHEMICALS IPO and ICICI BANK IPO.
DISHMAN PHARMACEUTICALS CHEMICALS IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while ICICI BANK IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| DISHMAN PHARMACEUTICALS CHEMICALS IPO | ICICI BANK IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | FPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | HSBC InvestDirect Securities (India) Ltd. Axis Capital Ltd. | |
| Registrar | MUFG Intime India Pvt.Ltd. | |
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus  | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of DISHMAN PHARMACEUTICALS CHEMICALS IPO is up to ₹60.09 Cr whereas the issue size of the ICICI BANK IPO is up to ₹3,500.00 Cr. The final issue price of DISHMAN PHARMACEUTICALS CHEMICALS IPO is ₹175.00 per share and of ICICI BANK IPO is ₹280.00 per share.
| DISHMAN PHARMACEUTICALS CHEMICALS IPO | ICICI BANK IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹155.00 per share | ₹255.00 per share |
| Issue Price (Upper) | ₹175.00 per share | ₹295.00 per share |
| Issue Price (Final) | ₹175.00 per share | ₹280.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 34,33,500 shares | 12,50,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹60.09 Cr | up to ₹3,500.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,33,500 shares | 12,50,00,000 shares |
| Issue Size Total (Amount) | up to ₹60.09 Cr | up to ₹3,500.00 Cr |
DISHMAN PHARMACEUTICALS CHEMICALS IPO opens on Mar 29, 2004, while ICICI BANK IPO opens on Apr 02, 2004. The closing date of DISHMAN PHARMACEUTICALS CHEMICALS IPO and ICICI BANK IPO is Apr 07, 2004, and Apr 07, 2004, respectively.
DISHMAN PHARMACEUTICALS CHEMICALS IPO P/E ratio is 12.64, as compared to ICICI BANK IPO P/E ratio of .
| DISHMAN PHARMACEUTICALS CHEMICALS IPO | ICICI BANK IPO | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.994 | ||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.99 | ||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.64 | ||||||||||||||||||||||||||||||||||||
| Market Cap | ₹240.34 Cr. | ||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||
| EPS | ₹13.84 | ||||||||||||||||||||||||||||||||||||
| RoNW | 30.74 | ||||||||||||||||||||||||||||||||||||
In the DISHMAN PHARMACEUTICALS CHEMICALS IPO Retail Individual Investors (RII) are offered 8,58,400 shares while in ICICI BANK IPO retail investors are offered 8,58,400 shares. Qualified Institutional Buyers (QIB) are offered 17,16,700 shares in DISHMAN PHARMACEUTICALS CHEMICALS IPO and 6,25,00,000 shares in ICICI BANK IPO.
| DISHMAN PHARMACEUTICALS CHEMICALS IPO | ICICI BANK IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 17,16,700 shares | 6,25,00,000 shares |
| NII | 8,58,400 shares | 3,12,50,000 shares |
| RII | 8,58,400 shares | 3,12,50,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 34,33,500 shares | 12,50,00,000 shares |
DISHMAN PHARMACEUTICALS CHEMICALS IPO subscribed in total, whereas ICICI BANK IPO subscribed .
